Capital International Investors Agios Pharmaceuticals, Inc. Transaction History

Capital International Investors

$511 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $4.02 Million - $5.58 Million	-95,882 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $5.4 Million - $7.02 Million	-122,168 Reduced 56.03%	95,882 $4.95 Million
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $107 Million - $150 Million	-3,217,303 Reduced 93.65%	218,050 $9.45 Million
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $14.2 Million - $23.5 Million	-419,479 Reduced 10.88%	3,435,353 $120 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $4.61 Million - $7.15 Million	-133,688 Reduced 3.35%	3,854,832 $206 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $17.2 Million - $29.3 Million	-544,294 Reduced 12.01%	3,988,520 $142 Million
Q4 2019 Feb 18, 2020	SELL	$30.08 - $50.59 $2.92 Million - $4.92 Million	-97,234 Reduced 2.1%	4,532,814 $216 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $44.4 Million - $68 Million	1,371,522 Added 42.09%	4,630,048 $150 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $490,002 - $722,745	10,613 Added 0.33%	3,258,526 $163 Million
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $677,044 - $997,726	14,744 Added 0.46%	3,247,913 $219 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $5.84 Million - $10.5 Million	136,747 Added 4.42%	3,233,169 $149 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $20.9 Million - $26.8 Million	291,393 Added 10.39%	3,096,422 $239 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $1.26 Million - $1.72 Million	-17,255 Reduced 0.61%	2,805,029 $236 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $549,359 - $794,518	9,182 Added 0.33%	2,822,284 $231 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $16.9 Million - $23.5 Million	-325,029 Reduced 10.36%	2,813,102 $161 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $172 Million - $211 Million	3,138,131	3,138,131 $209 Million

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

Farallon Capital Management LLC San Francisco, CA

5.67M
Shares

$193 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

5.63M
Shares

$192 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$165 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.52M
Shares

$120 Million
2.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.42M
Shares

$82.4 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.86B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account